A carregar...
Targeting PLKs as a Therapeutic Approach to Well-differentiated Thyroid Cancer
Polo-like kinases (PLKs) are pivotal regulators of cell proliferation and cell survival; therefore, PLKs may be potential targets in the treatment of malignancy. The therapeutic effects of volasertib, a PLKs inhibitor for papillary and follicular thyroid cancer (known as well-differentiated thyroid...
Na minha lista:
| Publicado no: | Endocr Relat Cancer |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7475022/ https://ncbi.nlm.nih.gov/pubmed/31189135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-18-0555 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|